Jangkwelaq Syrup (Lactulose Concentrate)

Adult dose

In cases of chronic constipation, typically administer 15 to 30 mL orally before breakfast for the first 2 to 3 days, then continue with 10 to 15 mL once a day. In severe cases, the dosage can be increased up to 45 mL.

Child dose

For children (ages 7 to 14), administer 15 mL once a day for the first 2 to 3 days, then continue with 10 mL once a day. For infants (ages 1 to 6), administer 5 to 10 mL once a day. For infants (under 12 months), administer 5 mL once a day.

This medication should not be taken by patients with inflammatory bowel disease, gastrointestinal obstruction, unexplained abdominal pain, and individuals with certain metabolic disorders such as lactose intolerance or galactosemia. Pregnant women, breastfeeding women, infants and young children, the elderly, and diabetic patients should consult a doctor or pharmacist before taking this medication. It is especially important for elderly patients to have their blood electrolyte levels checked regularly if they take this medication for more than 6 months. If there is fluid or electrolyte imbalance, this condition should be corrected before taking the medication, and patients with acute gastritis or chronic constipation should use special caution. Taking this medication with other medicines may increase gastrointestinal adverse reactions or decrease efficacy, so if you are taking acarbose, broad-spectrum antibiotics, diuretics, corticosteroids, cardiac glycosides, antacids, etc., you must consult with an expert. If there is no improvement in constipation after one week of use or if there is a sudden change in bowel habits, you should stop taking it and consult a doctor. In case of overdose, abdominal cramps or diarrhea and electrolyte loss may occur, so if you experience unusual symptoms, stop taking the medication immediately and seek appropriate treatment. Long-term use or overdose may lead to dependence of bowel reflex on the medication, so caution is necessary. If loose stools or diarrhea occur, it is advisable to reduce or discontinue the dosage. Gastrointestinal adverse symptoms such as belching, abdominal discomfort, diarrhea, abdominal pain, loss of appetite, nausea, and vomiting may occur. During rectal examination or colonoscopy, if high concentrations of hydrogen gas are present in the intestine, there is a risk of explosion, so complete bowel cleansing must be performed before examination. Long-term or excessive use may lead to fluid loss and electrolyte abnormalities, so caution is necessary. In pediatric patients, long-term use increases the risk of cavities, so special attention should be paid to dental hygiene. This medication should be kept out of the reach of children and stored securely in its original container.

Mild side effects

• Belching, cramping abdominal discomfort, diarrhea, abdominal distension, abdominal pain, loss of appetite, nausea, vomiting
• Fluid loss, hypokalemia, hypernatremia
• Risk of dental caries

Drug interactions

This medication may interact with α-glucosidase inhibitors such as acarbose, broad-spectrum antibiotics, diuretics, corticosteroids, amphotericin B, cardiac glycosides, and antacids, so it is necessary to consult a doctor or pharmacist.

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is advisable to maintain a storage temperature between 1°C and 30°C. This will help safely preserve the effectiveness of the medication.

Appearance

A colorless to yellow-brown viscous liquid in a white plastic bottle or aluminum pouch, presented as a syrup.

Package unit

15 mL per pouch, 30 pouches per box [15 mL/pouch x 30]